2005
Coupland SE, Hummel M, Stein H (2005) Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci,46(10),pp.3507-3514
Coupland SE, Loddenkemper C, Charlotte F, Smith JR, Hummel M, Stein H (2005) Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma. Invest Ophthalmol Vis Sci,46(11),pp.3957-3964
Jahnke K, Coupland SE, Na IK , Loddenkemper C, Thiel E, Keilholz U, Scheibenbogen C (2005) Expression of the chemokine receptors CXCR4, CXCR5 and CCR7 in primary central nervous system lymphoma. Blood,106(1),pp.384-385
Hughes S, Damato BE, Giddings I, Hiscott PS, Humphreys J, Houlston RS. Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3. Br J Cancer. 2005; 93: 1191-6.
Jose Luis Ordonez, Luminita Paraoan, Paul Hiscott, Donna Gray, Ian Grierson, Bertil Damato. Differential expression of angioregulatory matricellular proteins in posterior uveal melanoma. Melanoma Research 2005; 15: 495-502.
Purbrick RMJ, Tu KL, Damato B. The patient's role in the decision-making process - a perspective from the Liverpool Ocular Oncology Centre. Eye. 2005. (Epub ahead of print).
Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of iris melanoma. International Journal of Radiation Oncology*Biology*Physics. 2005; 63: 109-15. The first reported series.
Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge Experience. International Journal of Radiation Oncology*Biology*Physics 2005; 62: 1405-11.
Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Local tumor control after 106 brachytherapy of choroidal melanoma. International Journal of Radiation Oncology*Biology*Physics. 2005. 63; 385-391. The first paper on brachytherapy to report eccentric plaque positioning.
Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Visual acuity after ruthenium 106 brachytherapy of choroidal melanomas. International Journal of Radiation Oncology*Biology*Physics. 2005. 63; 392-400.
Ross JJ, Tu L, Damato B. Systemic remission of non-Hodgkin's lymphoma after intralesional interferon alpha-2b to bilateral conjunctival lymphomas. Am J Ophthalmol. 2004 Oct;138(4):672-3
Spendlove HE, Damato B, Humphreys H , Hiscott PS, Houlston RS. BRAF mutations are detectable in conjunctival but not intra-ocular uveal melanomas. Melanoma Research. 2004; 14: 449-52.
Damato B, Jones A. Uveal melanoma: resection techniques. Clinics of North America. 2005; 18: 119-28.
Coupland SE, Hummel M, Stein H (2005) Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci,46(10),pp.3507-3514
Coupland SE, Loddenkemper C, Charlotte F, Smith JR, Hummel M, Stein H (2005) Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma. Invest Ophthalmol Vis Sci,46(11),pp.3957-3964
Jahnke K, Coupland SE, Na IK , Loddenkemper C, Thiel E, Keilholz U, Scheibenbogen C (2005) Expression of the chemokine receptors CXCR4, CXCR5 and CCR7 in primary central nervous system lymphoma. Blood,106(1),pp.384-385
Hughes S, Damato BE, Giddings I, Hiscott PS, Humphreys J, Houlston RS. Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3. Br J Cancer. 2005; 93: 1191-6.
Jose Luis Ordonez, Luminita Paraoan, Paul Hiscott, Donna Gray, Ian Grierson, Bertil Damato. Differential expression of angioregulatory matricellular proteins in posterior uveal melanoma. Melanoma Research 2005; 15: 495-502.
Purbrick RMJ, Tu KL, Damato B. The patient's role in the decision-making process - a perspective from the Liverpool Ocular Oncology Centre. Eye. 2005. (Epub ahead of print).
Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of iris melanoma. International Journal of Radiation Oncology*Biology*Physics. 2005; 63: 109-15. The first reported series.
Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge Experience. International Journal of Radiation Oncology*Biology*Physics 2005; 62: 1405-11.
Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Local tumor control after 106 brachytherapy of choroidal melanoma. International Journal of Radiation Oncology*Biology*Physics. 2005. 63; 385-391. The first paper on brachytherapy to report eccentric plaque positioning.
Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Damato B, Patel I, Campbell IR, Mayles H, Errington RD. Visual acuity after ruthenium 106 brachytherapy of choroidal melanomas. International Journal of Radiation Oncology*Biology*Physics. 2005. 63; 392-400.
Ross JJ, Tu L, Damato B. Systemic remission of non-Hodgkin's lymphoma after intralesional interferon alpha-2b to bilateral conjunctival lymphomas. Am J Ophthalmol. 2004 Oct;138(4):672-3
Spendlove HE, Damato B, Humphreys H , Hiscott PS, Houlston RS. BRAF mutations are detectable in conjunctival but not intra-ocular uveal melanomas. Melanoma Research. 2004; 14: 449-52.
Damato B, Jones A. Uveal melanoma: resection techniques. Clinics of North America. 2005; 18: 119-28.
